Publication Date:
1990-03-23
Description:
EMT-6 murine mammary tumors were made resistant to cis-diamminedichloroplatinum (II) (CDDP), carboplatin, cyclophosphamide (CTX), or thiotepa in vivo by treatment of tumor-bearing animals with the drug during a 6-month period. In spite of high levels of in vivo resistance, no significant resistance was observed when the cells from these tumors were exposed to the drugs in vitro. The pharmacokinetics of CDDP and CTX were altered in animals bearing the respective resistant tumors. The resistance of all tumor lines except for the EMT-6/thiotepa decreased during 3 to 6 months in vivo passage in the absence of drugs. These results indicate that very high levels of resistance to anticancer drugs can develop through mechanisms that are expressed only in vivo.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Teicher, B A -- Herman, T S -- Holden, S A -- Wang, Y Y -- Pfeffer, M R -- Crawford, J W -- Frei, E 3rd -- P01-CA38497/CA/NCI NIH HHS/ -- New York, N.Y. -- Science. 1990 Mar 23;247(4949 Pt 1):1457-61.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Dana-Farber Cancer Institute, Boston, MA 02115.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/2108497" target="_blank"〉PubMed〈/a〉
Keywords:
Alkylating Agents/pharmacokinetics/*therapeutic use
;
Animals
;
Antineoplastic Agents/pharmacokinetics/*therapeutic use
;
Carboplatin
;
Cisplatin/therapeutic use
;
Cyclophosphamide/therapeutic use
;
Drug Resistance
;
Kidney/metabolism
;
Liver/metabolism
;
Mammary Neoplasms, Experimental/*drug therapy/metabolism
;
Mice
;
Mice, Inbred BALB C
;
Organoplatinum Compounds/therapeutic use
;
Sulfhydryl Compounds/analysis
;
Thiotepa/therapeutic use
;
Tissue Distribution
;
Tumor Cells, Cultured
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
